Oppenheimer Asset Management’s Encompass Health EHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.64M | Buy |
27,269
+2,956
| +12% | +$303K | 0.03% | 486 |
|
|
2025
Q4 | $2.58M | Sell |
24,313
-2,276
| -9% | -$264K | 0.03% | 456 |
|
|
2025
Q3 | $3.38M | Sell |
26,589
-443
| -2% | -$52.7K | 0.04% | 423 |
|
|
2025
Q2 | $3.31M | Buy |
27,032
+8,911
| +49% | +$1.02M | 0.04% | 431 |
|
|
2025
Q1 | $1.84M | Sell |
18,121
-650
| -3% | -$63.5K | 0.02% | 547 |
|
|
2024
Q4 | $1.73M | Sell |
18,771
-1,648
| -8% | -$162K | 0.02% | 579 |
|
|
2024
Q3 | $1.97M | Buy |
20,419
+71
| +0.3% | +$6.38K | 0.02% | 547 |
|
|
2024
Q2 | $1.75M | Sell |
20,348
-7,076
| -26% | -$594K | 0.02% | 567 |
|
|
2024
Q1 | $2.26M | Sell |
27,424
-529
| -2% | -$38.7K | 0.03% | 445 |
|
|
2023
Q4 | $1.87M | Sell |
27,953
-1,081
| -4% | -$70K | 0.03% | 534 |
|
|
2023
Q3 | $1.95M | Sell |
29,034
-417
| -1% | -$28.7K | 0.03% | 502 |
|
|
2023
Q2 | $1.99M | Sell |
29,451
-230
| -0.8% | -$14.4K | 0.03% | 509 |
|
|
2023
Q1 | $1.61M | Sell |
29,681
-1,387
| -4% | -$80.7K | 0.02% | 554 |
|
|
2022
Q4 | $1.86M | Sell |
31,068
-194
| -0.6% | -$10.6K | 0.03% | 502 |
|
|
2022
Q3 | $1.41M | Sell |
31,262
-9,533
| -23% | -$477K | 0.02% | 554 |
|
|
2022
Q2 | $1.82M | Sell |
40,795
-1,179
| -3% | -$60.5K | 0.03% | 495 |
|
|
2022
Q1 | $2.38M | Sell |
41,974
-420
| -1% | -$21.9K | 0.03% | 484 |
|
|
2021
Q4 | $2.2M | Buy |
42,394
+10,137
| +31% | +$523K | 0.03% | 526 |
|
|
2021
Q3 | $1.93M | Sell |
32,257
-669
| -2% | -$42.1K | 0.03% | 552 |
|
|
2021
Q2 | $2.04M | Buy |
32,926
+30
| +0.1% | +$2K | 0.03% | 527 |
|
|
2021
Q1 | $2.14M | Sell |
32,896
-396
| -1% | -$25.8K | 0.03% | 494 |
|
|
2020
Q4 | $2.19M | Sell |
33,292
-231
| -0.7% | -$13.6K | 0.04% | 464 |
|
|
2020
Q3 | $1.73M | Buy |
33,523
+974
| +3% | +$50K | 0.03% | 464 |
|
|
2020
Q2 | $1.6M | Sell |
32,549
-1,995
| -6% | -$108K | 0.03% | 454 |
|
|
2020
Q1 | $1.76M | Sell |
34,544
-265
| -0.8% | -$15.3K | 0.04% | 381 |
|
|
2019
Q4 | $1.92M | Sell |
34,809
-701
| -2% | -$38K | 0.04% | 423 |
|
|
2019
Q3 | $1.79M | Sell |
35,510
-1,060
| -3% | -$53.3K | 0.04% | 437 |
|
|
2019
Q2 | $1.84M | Buy |
36,570
+8,409
| +30% | +$408K | 0.04% | 429 |
|
|
2019
Q1 | $1.31M | Buy |
28,161
+9,141
| +48% | +$463K | 0.03% | 525 |
|
|
2018
Q4 | $934K | Sell |
19,020
-523
| -3% | -$29.7K | 0.02% | 587 |
|
|
2018
Q3 | $1.21M | Sell |
19,543
-17,262
| -47% | -$1.05M | 0.03% | 562 |
|
|
2018
Q2 | $1.98M | Sell |
36,805
-12,278
| -25% | -$614K | 0.05% | 399 |
|
|
2018
Q1 | $2.23M | Buy |
49,083
+4,891
| +11% | +$210K | 0.06% | 354 |
|
|
2017
Q4 | $1.63M | Hold |
44,192
| – | – | 0.04% | 438 |
|
|
2017
Q3 | $1.63M | Sell |
44,192
-3,507
| -7% | -$125K | 0.04% | 440 |
|
|
2017
Q2 | $1.84M | Sell |
47,699
-13,952
| -23% | -$511K | 0.05% | 383 |
|
|
2017
Q1 | $2.1M | Buy |
+61,651
| New | +$2.02M | 0.06% | 340 |
|
Other funds holding EHC
VPM
VCM
Oppenheimer Asset Management's EHC Position: Q1 2026 in Review
Oppenheimer Asset Management increased its Encompass Health (EHC) stake by 12% in Q1 2026, buying an estimated $303K and bringing the position to 27,269 shares worth $2.64M. The position accounts for 0.03% of the portfolio, ranked #486.
Oppenheimer Asset Management first reported a position in EHC in Q1 2017 and has held it in 37 quarters since. The position peaked at $3.38M in Q3 2025. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.
- Oppenheimer Asset Management held 27,269 shares of Encompass Health worth $2.64M as of Q1 2026.
- Oppenheimer Asset Management bought 2,956 Encompass Health shares in Q1 2026, an estimated $303K.
- Encompass Health made up 0.03% of Oppenheimer Asset Management's portfolio in Q1 2026, its #486 holding.
- Oppenheimer Asset Management first reported a position in Encompass Health in Q1 2017 and has held it in 37 quarters since.
- Oppenheimer Asset Management's Encompass Health position peaked at $3.38M in Q3 2025.
- 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.
Based on Oppenheimer Asset Management's 13F filing for Q1 2026, filed 24 Apr 2026.